Insulin autoimmunity: the rate limiting factor in pre-type I diabetes

George S. Eisenbarth, Richard A. Jackson, Alberto Pugliese

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Type I diabetes is preceded by a series of autoantibodies including recently recognized subtypes of cytoplasmic islet cell antibodies (ICA) which we have termed 'restricted' and 'non-restricted'. Amongst the autoantibodies detected in prediabetics the antibodies to insulin are unique in that their levels correlate with the rate of progression to type I diabetes. The levels of insulin autoantibodies appear to be stably regulated prior to the appearance of ICA and the highest levels are associated with expression of DR4. The above studies have led to the hypothesis that an immune response to insulin is an early and central feature of anti-islet autoimmunity and that such an immune response when associated with loss of tolerance to other islet antigens (e.g. ICA) is pathogenic.

Original languageEnglish
Pages (from-to)241-246
Number of pages6
JournalJournal of Autoimmunity
Volume5
Issue numberSUPPL. A
DOIs
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

Autoimmunity
Type 1 Diabetes Mellitus
Autoantibodies
Insulin
Insulin Antibodies
Antigens
islet cell antibody

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Insulin autoimmunity : the rate limiting factor in pre-type I diabetes. / Eisenbarth, George S.; Jackson, Richard A.; Pugliese, Alberto.

In: Journal of Autoimmunity, Vol. 5, No. SUPPL. A, 01.01.1992, p. 241-246.

Research output: Contribution to journalArticle

Eisenbarth, George S. ; Jackson, Richard A. ; Pugliese, Alberto. / Insulin autoimmunity : the rate limiting factor in pre-type I diabetes. In: Journal of Autoimmunity. 1992 ; Vol. 5, No. SUPPL. A. pp. 241-246.
@article{b9b8ddd894554e7b97d64697c6862e84,
title = "Insulin autoimmunity: the rate limiting factor in pre-type I diabetes",
abstract = "Type I diabetes is preceded by a series of autoantibodies including recently recognized subtypes of cytoplasmic islet cell antibodies (ICA) which we have termed 'restricted' and 'non-restricted'. Amongst the autoantibodies detected in prediabetics the antibodies to insulin are unique in that their levels correlate with the rate of progression to type I diabetes. The levels of insulin autoantibodies appear to be stably regulated prior to the appearance of ICA and the highest levels are associated with expression of DR4. The above studies have led to the hypothesis that an immune response to insulin is an early and central feature of anti-islet autoimmunity and that such an immune response when associated with loss of tolerance to other islet antigens (e.g. ICA) is pathogenic.",
author = "Eisenbarth, {George S.} and Jackson, {Richard A.} and Alberto Pugliese",
year = "1992",
month = "1",
day = "1",
doi = "10.1016/0896-8411(92)90039-S",
language = "English",
volume = "5",
pages = "241--246",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",
number = "SUPPL. A",

}

TY - JOUR

T1 - Insulin autoimmunity

T2 - the rate limiting factor in pre-type I diabetes

AU - Eisenbarth, George S.

AU - Jackson, Richard A.

AU - Pugliese, Alberto

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Type I diabetes is preceded by a series of autoantibodies including recently recognized subtypes of cytoplasmic islet cell antibodies (ICA) which we have termed 'restricted' and 'non-restricted'. Amongst the autoantibodies detected in prediabetics the antibodies to insulin are unique in that their levels correlate with the rate of progression to type I diabetes. The levels of insulin autoantibodies appear to be stably regulated prior to the appearance of ICA and the highest levels are associated with expression of DR4. The above studies have led to the hypothesis that an immune response to insulin is an early and central feature of anti-islet autoimmunity and that such an immune response when associated with loss of tolerance to other islet antigens (e.g. ICA) is pathogenic.

AB - Type I diabetes is preceded by a series of autoantibodies including recently recognized subtypes of cytoplasmic islet cell antibodies (ICA) which we have termed 'restricted' and 'non-restricted'. Amongst the autoantibodies detected in prediabetics the antibodies to insulin are unique in that their levels correlate with the rate of progression to type I diabetes. The levels of insulin autoantibodies appear to be stably regulated prior to the appearance of ICA and the highest levels are associated with expression of DR4. The above studies have led to the hypothesis that an immune response to insulin is an early and central feature of anti-islet autoimmunity and that such an immune response when associated with loss of tolerance to other islet antigens (e.g. ICA) is pathogenic.

UR - http://www.scopus.com/inward/record.url?scp=0026574043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026574043&partnerID=8YFLogxK

U2 - 10.1016/0896-8411(92)90039-S

DO - 10.1016/0896-8411(92)90039-S

M3 - Article

C2 - 1503616

AN - SCOPUS:0026574043

VL - 5

SP - 241

EP - 246

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

IS - SUPPL. A

ER -